Product Description
Human Lingual Cancer Stem Cell - Frozen Vial
Also Avaliable as:
T25 plated cells shipped at room temperature. Cat# 36062-02-T25
T75 plated cells shipped at room temperature. Cat# 36062-02-T75
T150 plated cells shipped at room temperature. Cat# 36062-02-T150
T225 plated cells shipped at room temperature. Cat# 36062-02-T225
120 Population doublings or up to 12 passages.
One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice.
This product would require pre-coated flasks with Human Lingual Cancer Stem Cell Extra-cellular Matrix Cat# E36062-02 and Human Lingual Cancer Stem Cell Media Cat# M36062-02
Cell Cultures from single donors, 1000 different cell cultures available, please indicate which lots you require from the 1000 donors.
Source: Lingual Tissue
Positive Markers: CD133, CD44, SSEA 3/4, Oct4, Tumorigenicity (<1000 cells), Alkaline Phosphatase, Aldehyde Dehydrogenase,
Telomerase, ESA, alpha5beta1 and alpha(v)beta6 integrins, cytokeratin 8 and phospholipase Cbeta2, Keratin 7, 8, and 19
For non-academic use, please inquire for pricing.
Cells are only guaranteed with purchase of Celprogen Media and Celprogen Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment.
1000 individual donors are fully characterized proprietary patient-derived xenografts (PDX) representing all major histotypes and capturing tumor diversity.
Subcutaneous, orthotopic and disseminated models. Extensive molecular and pharmacological characterization as well as information on patients' pretreatment to help you select the most appropriate model.
Integrated approach: use the same PDX models and/or the corresponding cell line in 2D/3D screening assays and follow-up in vivo studies, identify biomarkers predicting tumor sensitivity for your compound.
Individually tailored study designs: proof of concept, dose level and schedule optimization, combinations, biomarker identification, etc.
Publication
The Role of CXCR3/Ligand Axis in Cancer
Biomolecular Characterization of Exosomes Released from CSC
Dietary Bioflavonoid Quercetin Synergizes
Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4
New Therapy Targeting Differential Androgen Receptor Signaling in Prostate CSC
NVP-LDE-225 (Erismodegib) Inhibits Epithelial-Mesenchymal Transition
Rottlerin Induces Autophagy and Apoptosis in Prostate CSC
Synthetic Lethality as a Targeted Approach to Advanced Prostate
TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem. Progenitor Cell
Triphala Extract Suppresses Proliferation and Induces Apoptosis
Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer
